| Protein FDR Confidence: Combined | Accession | Description | Exp. q-value: Combined | Sum PEP Score | Coverage [%] | # Peptides | # PSMs | # Unique Peptides | # AAs | MW [kDa] | calc. pI | Abundance Ratio: (DKO) / (WT) | Abundance Ratio: (SKO) / (WT) | Abundance Ratio (log2): (DKO) / (WT) | Abundance Ratio (log2): (SKO) / (WT) | Abundance Ratio P-Value: (DKO) / (WT) | Abundance Ratio P-Value: (SKO) / (WT) | Abundance Ratio Adj. P-Value: (DKO) / (WT) | Abundance Ratio Adj. P-Value: (SKO) / (WT) | Abundances (Grouped): DKO | Abundances (Grouped): SKO | Abundances (Grouped): WT | Abundances (Grouped) CV [%]: DKO | Abundances (Grouped) CV [%]: SKO | Abundances (Grouped) CV [%]: WT | Abundances (Scaled): F1: 127C, Sample, DKO, 1 | Abundances (Scaled): F1: 128C, Sample, DKO, 2 | Abundances (Scaled): F1: 129C, Sample, DKO, 3 | Abundances (Scaled): F1: 130C, Sample, DKO, 4 | Abundances (Scaled): F1: 129N, Sample, SKO, 1 | Abundances (Scaled): F1: 130N, Sample, SKO, 2 | Abundances (Scaled): F1: 131, Sample, SKO, 3 | Abundances (Scaled): F1: 126, Sample, WT, 1 | Abundances (Scaled): F1: 127N, Sample, WT, 2 | Abundances (Scaled): F1: 128N, Sample, WT, 3 | Abundances (Normalized): F1: 127C, Sample, DKO, 1 | Abundances (Normalized): F1: 128C, Sample, DKO, 2 | Abundances (Normalized): F1: 129C, Sample, DKO, 3 | Abundances (Normalized): F1: 130C, Sample, DKO, 4 | Abundances (Normalized): F1: 129N, Sample, SKO, 1 | Abundances (Normalized): F1: 130N, Sample, SKO, 2 | Abundances (Normalized): F1: 131, Sample, SKO, 3 | Abundances (Normalized): F1: 126, Sample, WT, 1 | Abundances (Normalized): F1: 127N, Sample, WT, 2 | Abundances (Normalized): F1: 128N, Sample, WT, 3 | Abundance: F1: 127C, Sample, DKO, 1 | Abundance: F1: 128C, Sample, DKO, 2 | Abundance: F1: 129C, Sample, DKO, 3 | Abundance: F1: 130C, Sample, DKO, 4 | Abundance: F1: 129N, Sample, SKO, 1 | Abundance: F1: 130N, Sample, SKO, 2 | Abundance: F1: 131, Sample, SKO, 3 | Abundance: F1: 126, Sample, WT, 1 | Abundance: F1: 127N, Sample, WT, 2 | Abundance: F1: 128N, Sample, WT, 3 | Abundances Count: F1: 127C, Sample, DKO, 1 | Abundances Count: F1: 128C, Sample, DKO, 2 | Abundances Count: F1: 129C, Sample, DKO, 3 | Abundances Count: F1: 130C, Sample, DKO, 4 | Abundances Count: F1: 129N, Sample, SKO, 1 | Abundances Count: F1: 130N, Sample, SKO, 2 | Abundances Count: F1: 131, Sample, SKO, 3 | Abundances Count: F1: 126, Sample, WT, 1 | Abundances Count: F1: 127N, Sample, WT, 2 | Abundances Count: F1: 128N, Sample, WT, 3 | Biological Process | Cellular Component | Molecular Function | Pfam IDs | Entrez Gene ID | Gene Symbol | Chromosome | Reactome Pathways | Ensembl Gene ID | KEGG Pathways | WikiPathways | # Razor Peptides | Modifications |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| High | P46414 | Cyclin-dependent kinase inhibitor 1B OS=Mus musculus OX=10090 GN=Cdkn1b PE=1 SV=2 | 0.002 | 4.149 | 8 | 2 | 2 | 2 | 197 | 22.2 | 7.02 | 0.564 | 0.748 | -0.83 | -0.42 | 0.498859098 | 0.218882523 | 0.999945597 | 0.87126064 | 73.2 | 97.1 | 129.7 | 8.92 | 13.71 | 18.06 | 68 | 82.6 | 73.7 | 81 | 105.8 | 102.5 | 81.4 | 137 | 158.3 | 109.6 | 18.2 | 22.1 | 19.8 | 21.7 | 28.4 | 27.5 | 21.8 | 36.7 | 42.4 | 29.4 | 14.2 | 19.1 | 17.6 | 18.8 | 26.5 | 22.4 | 21.8 | 33.6 | 37.4 | 27.1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | cell death;regulation of biological process;response to stimulus;transport | cytoplasm;cytosol;endosome;nucleus | catalytic activity;enzyme regulator activity;protein binding | Pf02234 | 12576 | Cdkn1b | 6 | Removal of licensing factors from origins; Regulation of APC/C activators between G1/S and early anaphase; TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest; Orc1 removal from chromatin; Senescence-Associated Secretory Phenotype (SASP); DNA Damage/Telomere Stress Induced Senescence; p53-Dependent G1 DNA Damage Response; Cyclin D associated events in G1; PTK6 Regulates Cell Cycle; SCF(Skp2)-mediated degradation of p27/p21; AKT phosphorylates targets in the cytosol; Regulation of DNA replication | ENSMUSG00000003031.14 | ErbB signaling pathway; FoxO signaling pathway; AGE-RAGE signaling pathway in diabetic complications; MicroRNAs in cancer; Epstein-Barr virus infection; Small cell lung cancer; Hepatitis B; Transcriptional misregulation in cancer; Cell cycle; HIF-1 signaling pathway; Pathways in cancer; PI3K-Akt signaling pathway; Viral carcinogenesis; Chronic myeloid leukemia; Measles; Prostate cancer; Endocrine resistance | ErbB signaling pathway; Oxidative Damage; IL-5 Signaling Pathway; miRNA regulation of DNA Damage Response; Primary Focal Segmental Glomerulosclerosis FSGS; Ovarian Infertility Genes; Focal Adhesion-PI3K-Akt-mTOR-signaling pathway; miR-222 in Exercise-Induced Cardiac Growth; Dysregulated miRNA Targeting in Insulin/PI3K-AKT Signaling; G1 to S cell cycle control | 0 |